Nu Holdings, the parent of Nubank, is trading around $13.16, down 30% from its highs but showing strong fundamentals with over 135 million customers and its first $5 billion revenue quarter. Despite a recent market pullback due to rising credit losses and non-performing loans, the company reports 41% net income growth and a 30.1% return on equity. Analysts remain optimistic with an average price target of $19.43, highlighting growth potential in Brazil, Mexico, and upcoming U.S. expansion. Investors should consider credit risks and currency exposure but see the current price as a compelling entry point for emerging-market fintech exposure.
The Latin American alternative lending market is projected to grow at a 14.4% CAGR from 2026 to 2029, reaching approximately $10 billion by 2029, up from $5.9 billion in 2025. Growth is fueled by expanding e-commerce, integration of credit into digit...
Nu Holdings reported robust growth with a 29% return on equity and an expanding loan portfolio, signaling strong profitability. Despite some short-term earnings volatility due to higher expected credit losses and a declining ROE, the company's Q1 rev...
Nu Holdings has seen its market value fall over 35% since January, underperforming other Brazilian banks. Despite this, it remains a high-growth bank with strong return on equity (ROE) and significant expansion opportunities. In Brazil, Nu captures o...
Stocks priced under $30 often get overlooked, but Pfizer and Nu Holdings stand out with solid balance sheets and growth potential. Pfizer, a global biopharma giant, trades around $25 with a strong dividend yield and promising pipeline despite some re...
Nu Holdings is initiated with a buy rating due to its strong year-over-year customer and financial growth, including 42% revenue increase and improved efficiency. Despite some mixed quarter-over-quarter trends, the company is expanding market share a...
